Class IIOngoing
OurPharma LLC recalls fentaNYL Citrate
Recall date · record updated Sep 16, 2026 · Source: U.S. Food and Drug Administration (openFDA drug enforcement)
Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.
- Company
- OurPharma LLC
- Reason
- Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026).
- Hazard
- FDA Class II: may cause temporary or medically reversible adverse health consequences (FDA definition).
- Who’s affected
- Nationwide within the U.S
- Where
- Nationwide
- Official notice
- www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99837…
Products
fentaNYL Citrate, 1,000 mcg/100 mL (10mcg/mL) Injection solution in 100 mL, 0.9% NaCl Bag, OurPharma LLC, 2512 S. City Lake, Fayetteville, AR, NDC 73013-1013-01.
Codes/lots: Lot #: 101301260605, BUD: 12/9/2026.Quantity: 1,610 bagsRecall no. D-0864-2026Class II
Update history
- First listed on OVERLOOKED from the official record.
When the agency expands or changes this recall, we update this page and log the change here.
Proof: raw official record (JSON) · fetched from FDA API
More Medicines & devices recalls
Medicines & devicesClass II
American Health Packaging recalls Metoclopramide Tablets
Presence of Foreign Tablets/Capsules
· FDA · Nationwide
Medicines & devicesClass II
Zydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for Injection
Failed Impurities/Degradation Specifications.
· FDA · Nationwide
Medicines & devicesClass II
Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets
Presence of Foreign Tablets/Capsules
· FDA · Nationwide